Polylactide-Based Reactive Micelles as a Robust Platform for mRNA Delivery

Céline Lacroix1, Almudena Humanes1, Céline Coiffier1

  • 1Biologie Tissulaire et Ingénierie Thérapeutique, IBCP, Université Lyon 1, CNRS, UMR 5305, 69367, Lyon, France.

Pharmaceutical Research
|January 10, 2020
PubMed
Abstract

Insights

This study developed poly(D,L-lactide) (PLA)-based micelles for messenger RNA (mRNA) delivery. The novel micellar carriers effectively protected mRNA from degradation and showed improved transfection in dendritic cells compared to peptide-mRNA complexes.

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Drug Delivery Systems

Background:

  • Messenger RNA (mRNA) therapeutics offer significant potential but face challenges in stability and endosomal escape.
  • Effective delivery systems are crucial for mRNA's therapeutic applications.

Purpose of the Study:

  • To design and evaluate poly(D,L-lactide) (PLA)-based micelles for enhanced mRNA delivery.
  • To overcome mRNA instability and endosomal entrapment using a novel micelle platform.

Main Methods:

  • Two strategies, layer-by-layer (LbL) and peptide-mRNA pre-complex (PC), were used to immobilize mRNA onto PLA micelles.
  • Characterization included size, charge, mRNA protection, serum stability, cytotoxicity, and transfection efficiency in dendritic cells (DCs).

Main Results:

  • Micellar assemblies provided complete mRNA protection in serum, unlike peptide-mRNA complexes which led to degradation.
  • PLA micelles significantly reduced toxicity compared to peptide-mRNA complexes.
  • The LbL approach demonstrated superior transfection efficiency in hard-to-transfect DCs.

Conclusions:

  • The developed PLA/peptide micelle platform is a promising system for improving mRNA stability and delivery.
  • This platform offers potential for further functionalization via PLA core encapsulation.